由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Medicine版 - 求药
相关主题
急问:怎么在美国购买抗癌药物求助:爸爸血小板只有两万,怎么也升不上去
请教多发性骨髓瘤的治疗这真的是骨髓癌晚期?
求助:多发性骨髓瘤药new drugs for multiple myeloma求助:来纳度胺(治疗多发性骨髓炎的药物)
请教多发性骨髓瘤 (multiple myeloma) (转载)求助: 多发性骨髓瘤
急问:如何帮在国内的亲人买美国的处方药?请教个问题
帮国内亲戚问个急病 (转载)询问关于“多发性骨髓瘤”
[求助] 多发性骨髓瘤-悲惨人生请教多发性骨髓瘤
求助:多发性骨髓瘤λ轻链型!重生手记与多发性骨髓瘤
相关话题的讨论汇总
话题: mephalan话题: government话题: low话题: china话题: gsk
进入Medicine版参与讨论
1 (共1页)
e*****t
发帖数: 110
1
朋友家的老人被诊断出多发性骨髓瘤,想用一种副作用比较小的化疗药,国内没有卖的
,是处方药。不知道版上有人能帮忙否,万分感谢,请站内联系。
中文名字马法兰,英文名melphalan,商品名Alkeran,针对multiple myeloma。如果可
能,先开4盒片剂
l*h
发帖数: 4124
2
the government's pricing policy has to blame for the shortage of melphalan.
the government limited the prices of some of those classic and effective
drugs to such low levels that they are below the cost (both manufacturing
and distribution). take mephalan as an example, it must be refrigerated
therefore the cost of transportation and distribution is high. GSK simply
cannot do it any more with such a pricing policy. Even now the price of
bootlegged mephalan from Hong Kong is still quite low (~ RMB 100 for a month
's supply). You can imagine how low the price was for GSK to supply
hospitals and drugstores in China.
mephalan is easy to manufacture. it doesn't have patent protection any more.
but the government-determined price is so low even drugmakers in China don'
t want to make it.
on the other hand, the government allows many other drugs to charge
exorbitant prices, depending on how well you bribe the officials.

【在 e*****t 的大作中提到】
: 朋友家的老人被诊断出多发性骨髓瘤,想用一种副作用比较小的化疗药,国内没有卖的
: ,是处方药。不知道版上有人能帮忙否,万分感谢,请站内联系。
: 中文名字马法兰,英文名melphalan,商品名Alkeran,针对multiple myeloma。如果可
: 能,先开4盒片剂

1 (共1页)
进入Medicine版参与讨论
相关主题
重生手记与多发性骨髓瘤急问:如何帮在国内的亲人买美国的处方药?
重生手记与多发性骨髓瘤(附件)帮国内亲戚问个急病 (转载)
翻译病历[求助] 多发性骨髓瘤-悲惨人生
【急求】关于多发性骨髓瘤的美国专家,有懂这方面的请和我联系求助:多发性骨髓瘤λ轻链型!
急问:怎么在美国购买抗癌药物求助:爸爸血小板只有两万,怎么也升不上去
请教多发性骨髓瘤的治疗这真的是骨髓癌晚期?
求助:多发性骨髓瘤药new drugs for multiple myeloma求助:来纳度胺(治疗多发性骨髓炎的药物)
请教多发性骨髓瘤 (multiple myeloma) (转载)求助: 多发性骨髓瘤
相关话题的讨论汇总
话题: mephalan话题: government话题: low话题: china话题: gsk